Navigation Links
MDS Responds to AECL and Government of Canada Announcements Regarding Maple Project

TORONTO, May 16 /PRNewswire-FirstCall/ - Earlier this morning, Atomic Energy of Canada Ltd. (AECL) announced it would discontinue the development of the MAPLE reactors at Chalk River, but remains committed to providing ongoing supply of medical isotopes.

MDS Inc., a leading provider of products and services to the global life sciences markets, was not consulted by AECL about this decision, and the company is evaluating these developments. MDS Nordion, a business unit of MDS, is a leading provider of medical isotopes and radiopharmaceuticals.

"The most important issue has always been the continuity of medical isotope supply for patients worldwide," said Stephen P. DeFalco, President and CEO, MDS Inc. "We are pleased that the government has asked AECL to pursue the extension of the NRU operation beyond its current license and to ensure the ongoing supply of these critical medical isotopes."

MDS is disappointed that AECL has stated it will not complete the MAPLE project despite significant investment and effort over the past 12 years. The company will evaluate all options and pursue appropriate steps to protect the interests of patients, its customers and its shareholders.

About MDS

MDS Inc. (TSX: MDS; NYSE: MDZ) is a global life sciences company that provides market-leading products and services that our customers need for the development of drugs and the diagnosis and treatment of disease. We are a leading global provider of pharmaceutical contract research, medical isotopes for molecular imaging, radiotherapeutics, and analytical instruments. MDS has more than 5,500 highly skilled people in 29 countries. Find out more at or by calling 1-888-MDS-7222, 24 hours a day.

Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Undeterred Despite the Obstacles: American Refugee Committee Responds to Tragedy in Myanmar
2. Aid Urgently Needed in Myanmar (Burma): Lutheran World Relief Responds
3. Neuralstem Responds to Incorrect StemCells, Inc. Release on Patents
4. Terumo Cardiovascular Systems Responds to Allegations of Patent Infringement
5. The Toy Industry Association Responds to Washington State Law Governing the Sale of Toys and the Governors Veto of Key Sections of the Bill
6. Biotest Pharmaceuticals Corporation Responds to Orphan Drug Act Announcement
7. DRAXIS Responds to Trading
8. Maternal love: How a mothers brain responds to her infant
9. DuPont Responds to Spelter, W.Va. Lawsuit Rulings
10. Blue Cross of California Responds to Recent Media Coverage of Rescission
11. Veterans for Americas (VFA) Wounded Warrior Outreach Program Responds to Fort Drum in Aftermath of Report
Post Your Comments:
(Date:11/26/2015)... ... 2015 , ... The Catalent Applied Drug Delivery Institute today ... dose form selection in early phase drug development. The first of these is ... together the UK’s emerging life sciences companies, corporate partners, and investors, at Milton ...
(Date:11/26/2015)... ... November 26, 2015 , ... PRMA Plastic Surgery is updating ... our surgeons performed their 6,000th free flap breast reconstruction surgery! , “What an accomplishment ... day excited to rebuild lives and it’s an honor to have served all of ...
(Date:11/26/2015)... ... 26, 2015 , ... Pixel Film Studios brings Final Cut ... Vintage. This newly styled ProTrailer pack comes with 30 all-new vintage-inspired designs, with ... users limitless opportunities to stylize and create designs quickly and easily, all within ...
(Date:11/26/2015)... , ... November 26, 2015 , ... Indosoft Inc., developer ... of an application server to improve system efficiency and reliability. , The new Q-Suite ... of these standards, the system avoids locking itself into a specific piece of software ...
(Date:11/25/2015)... ... November 25, 2015 , ... As part of a global ... attracts volunteers together who want to combine talents and resources to help create ... the process. The non-profit launched its first major fundraiser on November 6, 2015 ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 26, 2015 ... addition of the "2016 Future Horizons ... of Abuse Testing Market: Supplier Shares, Country ... report to their offering. --> ... the "2016 Future Horizons and Growth ...
(Date:11/26/2015)... 26, 2015 ... of the  "2016 Future Horizons and ... Drug Monitoring (TDM) Market: Supplier Shares, ... Opportunities"  report to their offering.  ... the addition of the  "2016 Future ...
(Date:11/26/2015)... Nov. 26, 2015 Research and Markets ... the "2016 Future Horizons and Growth Strategies ... Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging ... --> --> This ... the Italian therapeutic drug monitoring market, including emerging ...
Breaking Medicine Technology: